Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
Cash Flow PerformanceCompressed
Percentile Rank29
Studio
Year-over-Year Change

Free cash flow yield

Percentile
P29
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
2 yr
Consecutive growthCompressed
PeriodValueYoY Change
2025-25.33%+35.2%
2024-39.10%+11.3%
2023-44.08%-160.8%
202272.51%+1250.8%
2021-6.30%+1.0%
2020-6.37%+10.2%
2019-7.09%-4.3%
2018-6.80%-